Q8CB44
Gene name |
Gramd4 |
Protein name |
GRAM domain-containing protein 4 |
Names |
Death-inducing protein |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:223752 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q8CB44
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q8CB44-F1 | Predicted | AlphaFoldDB |
26 variants for Q8CB44
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs234160199 | 20 | S>F | No | EVA | |
| rs3389395244 | 41 | V>I | No | EVA | |
| rs3389360553 | 46 | R>S | No | EVA | |
| rs3405501417 | 51 | N>D | No | EVA | |
| rs3406472046 | 61 | F>W | No | EVA | |
| rs236894582 | 69 | L>F | No | EVA | |
| rs3406354176 | 76 | P>S | No | EVA | |
| rs3389299090 | 90 | K>E | No | EVA | |
| rs3389375112 | 92 | P>L | No | EVA | |
| rs3389360530 | 110 | T>N | No | EVA | |
| rs3389389180 | 156 | T>I | No | EVA | |
| rs3389389167 | 163 | Q>H | No | EVA | |
| rs3389332229 | 173 | I>T | No | EVA | |
| rs3389395220 | 187 | S>P | No | EVA | |
| rs230045118 | 194 | P>S | No | EVA | |
| rs3389299141 | 207 | G>C | No | EVA | |
| rs3389384506 | 227 | E>* | No | EVA | |
| rs3406493996 | 249 | E>A | No | EVA | |
| rs3389389191 | 409 | Y>* | No | EVA | |
| rs3389343528 | 448 | W>C | No | EVA | |
| rs3406098689 | 463 | A>D | No | EVA | |
| rs3389380999 | 524 | C>F | No | EVA | |
| rs3389373624 | 538 | I>M | No | EVA | |
| rs3389395219 | 547 | E>G | No | EVA | |
| rs3406568408 | 600 | P>A | No | EVA | |
| rs3406410525 | 600 | P>R | No | EVA |
No associated diseases with Q8CB44
Functions
4 GO annotations of cellular component
| Name | Definition |
|---|---|
| endoplasmic reticulum membrane | The lipid bilayer surrounding the endoplasmic reticulum. |
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| mitochondrial membrane | Either of the lipid bilayers that surround the mitochondrion and form the mitochondrial envelope. |
| mitochondrion | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. |
No GO annotations of molecular function
| Name | Definition |
|---|---|
| No GO annotations for molecular function |
3 GO annotations of biological process
| Name | Definition |
|---|---|
| apoptotic process | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
| negative regulation of toll-like receptor 9 signaling pathway | Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 9 signaling pathway. |
| positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | Any process that activates or increases the activity of a cysteine-type endopeptidase involved in the apoptotic process. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MGIASHSAFR | ERESSPTGAS | LDASPRPWDK | GLSGREPPRH | VQVRPRSAVL | NMLRRLDRIR |
| 70 | 80 | 90 | 100 | 110 | 120 |
| FRGHKREDLL | DLAESPNASD | TECGDEIPLK | TPRPSPRDSE | ELRDPAGPGT | LIMAAGVQDF |
| 130 | 140 | 150 | 160 | 170 | 180 |
| NRTEFDRLNE | IKGHLEIALL | EKHFLQEELR | KLREETNSEM | LRQELDRERQ | RRIELEQKMQ |
| 190 | 200 | 210 | 220 | 230 | 240 |
| EVLKARSEEQ | PAQPQQPPKG | QSQASNGTGT | ERRSQGLASR | VQKWFYERFG | EYIEDFRFQP |
| 250 | 260 | 270 | 280 | 290 | 300 |
| EENTVETEEP | LSARRLTENM | RRLKRGAKPV | TNFVKNLSAL | SDWYSIYTSA | IAFTVYMNAV |
| 310 | 320 | 330 | 340 | 350 | 360 |
| WHGWAIPMFL | FLAILRLSLN | YLIARGWRIQ | WSIVPEVSEA | VEPAKEDLTV | SEKFQLVLDV |
| 370 | 380 | 390 | 400 | 410 | 420 |
| AQKAQNLFGK | MADILEKIKN | LFMWVQPETT | QKLYVALWAA | FLASCFFPYR | LVGLAVGLYA |
| 430 | 440 | 450 | 460 | 470 | 480 |
| GIKFFLIDFI | FKRCPRLRAK | YDTPYIIWRS | LPTDPQLKER | AGATVSRRLQ | TASSRSYVSS |
| 490 | 500 | 510 | 520 | 530 | 540 |
| APAGLSKDED | AGRFHSTKKG | NFHEIFNLTE | NERPLAVCEN | GWRCCLINRD | RKMPTDYIRN |
| 550 | 560 | 570 | 580 | 590 | 600 |
| GVLYVTENYL | CFESSKSGSS | KRNKVIKLMD | ITDIQKYKVL | SVLPGSGMGI | AVSTPSTQKP |
| 610 | 620 | 630 | |||
| LVFGAMVHRD | EAFETIFSQY | VKITSAAASG | GDS |